Angiotensin-converting enzyme inhibitor therapy: Adverse effects encountered by the otolaryngologist

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 9, Issue 3, 2001, Pages 162-165

  Sadeghi, Nader ^a,c   Panje, William R ^b  

^a MCGILL UNIVERSITY   (Canada)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; CANDESARTAN; CROMOGLYCATE DISODIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IRBESARTAN; LOSARTAN; PROSTAGLANDIN INHIBITOR; STEROID; TELMISARTAN; VALSARTAN;

ANGIONEUROTIC EDEMA; ANTIHYPERTENSIVE THERAPY; CLINICAL FEATURE; COUGHING; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; ORTHOSTATIC HYPOTENSION; OTORHINOLARYNGOLOGY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; SURVIVAL; TOXIC EPIDERMAL NECROLYSIS; VERTIGO;

EID: 0035001363     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-200106000-00009     Document Type: Short Survey

References (39)

1. 1 Sever P, Beevers G, Bulpitt C, et al.: Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ 1993, 306:983-987.
2. 2 Edwards CRW, Padfield PL: Angiotensin-converting enzyme inhibitors: past, present and bright future. Lancet 1985, i:30-34.
3. 3 The Studies of Left Ventricular Dysfunction Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991, 325:293-302.
4. 4 Hollenberg NK: The renin-angiotensin system and cardiovascular disease. Blood Press 2000, 9(suppl 1):5-8.
5. 5 Croog SH, Levine S, Testa MA, et al.: The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986, 314:1657-1664.
6. 6 Pylypchuk GB: ACE inhibitor-versus angiotensin II blocker-induced cough and angioedema. Ann Pharmacol 1998, 32:1060-1066.
7. 7 Herman RJ, Pylypchuk GB, Evans BL: Prevalence and incidence of cough in patients on treatment with angiotensin converting enzyme inhibitors [abstract]. Clin Pharmacol Ther 1996, 59:139.
8. 8 Coulter DM, Edwards IR: Cough associated with captopril and enalapril. BMJ 1987, 194:1521-1523.
9. 9 Gibson GR: Enalapril-induced cough. Arch Intern Med 1989, 149:2701-2703.
10. 10 Olsen CG: Delay of diagnosis and empiric treatment of angiotensin-converting enzyme inhibitor-induced cough in office practice. Arch Fam Med 1995, 4:525-528.
11. 11 Ding PYA, Hu OYP, Pool PE, et al.: Does Chinese ethnicity affect the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors? J Hum Hypertens 2000, 14:163-170.
12. 12 Tenenbaum A, Grossman E, Shemesh J, et al.: Intermediate but not low doses of aspirin can suppress angiotensin-converting enzyme inhibitor-induced cough. Am J Hypertens 2000, 13:776-782. Well-designed clinical trial examining the use of aspirin in treating ACEI-induced cough.
13. 13 Hargreaves MR, Benson MK: Inhaled sodium cromoglycate in angiotensin-converting enzyme inhibitor cough. Lancet 1995, 345:13-16.
14. 14 Martin DJ, Grigg RG, Tomkinson A, et al.: Subglottic stenosis: an unusual presentation of ACE inhibitor-induced angioedema. Aust N Z J Surg 1999, 69:320-321.
15. 15 Greaves M, Lawlor F: Angioedema: manifestations and management. J Am Acad Dermatol 1991, 25:155-165.
16. 16 Jacobs RL, Hoberman Ll, Goldstein HM: Angioedema of the small bowel caused by an angiotensin-converting enzyme inhibitor. Am J Gastroenterol 1994, 89:127-128.
17. 17 Seidman MD, Lewandowsky CA, Sarpa JR, et al.: Angioedema related to angiotensin-converting enzyme inhibitors. Otolaryngol Head Neck Surg 1990, 102:727-731.
18. 18 Pigman EC, Scott JL: Angioedema in the emergency department: the impact of angiotensin-converting enzyme inhibitors. Am J Emerg Med 1993, 11:350-354.
19. 19 Barna JS, Frable MAS: Life-threatening angioedema. Otolaryngol Head Neck Surg 1990, 103:795-798.
20. 20 Thompson T, Frable AS: Drug-induced, life-threatening angioedema revisited. Laryngoscope 1993, 103:10-12.
21. 21 Kharasch ED: Angiotensin-converting enzyme inhibitor-induced angioedema associated with endotracheal intubation. Anesth Analg 1992, 74:602-603.
22. 22 Hedner T, Samuelsson O, Lunde H, et al.: Angioedema in relation to treatment with angiotensin converting enzyme inhibitors. BMJ 1992, 304:941-946.
23. 23 Slater EE, Merril DD, Guess HA, et al.: Clinical profile of angioedema with angiotensin-converting enzyme inhibition. JAMA 1988, 260:967-970. Although this article is an older study, it is an excellent study of the incidence and prevalence of ACEI-induced angioedema, involving a large number of patients (n = 12000) treated with an ACEI (enalapril).
24. 24 Finley CJ, Silverman MA, Nunez AE: Angiotensin-converting enzyme inhibitor-induced angioedema: still unrecognized. Am J Emerg Med 1992, 10:550-552.
25. 25 Chin HL, Buchan DA: Severe angioedema after long-term use of an angiotensin-converting enzyme inhibitor. Ann Intern Med 1990, 112:312-313.
26. 26 Gannon TH, Edy TL: Angioedema from angiotensin converting enzyme inhibitors: a cause of upper airway obstruction. Laryngoscope 1990, 100:1156-1160.
27. 27 Giannoccaro PJ, Wallace GJ, Higginson LAJ, et al.: Fatal angioedema associated with enalapril. Can J Cardiol 1989, 5:335-336.
28. 28 Israili ZH, Hall D: Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy: a review of the literature and pharmacology. Ann Intern Med 1992, 117:234-237.
29. 29 Sadeghi N, Panje WR: Life-threatening perioperative angioedema related to angiotensin-converting enzyme inhibitor therapy. J Otolaryngol 1999, 28:354-356.
30. 30 Rotmensch HH, Vlasses PH, Ferguson RK: Angiotensin-converting enzyme inhibitors. Med Clin North Am 1988, 72:399-425.
31. 31 Sabroe RA, Black AK: Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema. Br J Dermatol 1997, 136:153-158.
32. 32 Marceau F: Is there a role for bradykinin in the therapeutic and side effects of angiotensin-converting enzyme inhibitors? Can J Cardiol 1997, 13:187-194. Excellent critical review of the role of bradykinin in the therapeutics and side effects of ACEIs.
33. 33 Brown NJ, Ray WA, Snowden M, et al.: Black Americans have an increased rate of angiotensin-converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther 1996, 60:8-13.
34. 34 Jain M, Armstrong L, Hall J: Predisposition to and late onset of upper airway obstruction following angiotensin-converting enzyme inhibitor therapy. Chest 1992, 102:871-874.
35. 35 Megerian CA, Arnold JE, Berger M: Angioedema: 5 years' experience, with a review of the disorder's presentation and treatment. Laryngoscope 1992, 102:256-260.
36. 36 Warner KK, Visconti JA, Tschampel MM: Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema. Ann Pharmacol 2000, 34:526-528. Review of angioedema associated with angiotensin II receptor blockers. These medications are used when persistent cough prevents the use of ACEIs; however, they may also cause angioedema, especially when the patient has a history of ACEI-associated angioedema.
37. 37 Johnston CI: Angiotensin II type 1 receptor blockade: a novel therapeutic concept. Blood Press 2000, 9(suppl 1):9-13. Good review of this target-specific medication that provides the same degree of target organ protection in hypertension as ACEIs without the class-specific side effects of ACEIs.
38. 38 Jafari DR: Angiotensin II-receptor antagonists: an overview. Am J Health Syst Pharm 2000, 57:1231-1241.
39. 39 Brown RS, Krakow AM, Douglas T, et al.: "Scalded mouth syndromecaused by angiotensin converting enzyme inhibitors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997, 83:665-667.